Endometriosis Treatment in India: From NSAIDs to Excision Surgery

• Endometriosis affects roughly 1 in 10 reproductive-age women; in India diagnosis is still typically delayed 7–10 years because pain is normalised.
• Treatment is a ladder, not a single fix: NSAIDs and hormones first, surgery when symptoms or fertility need it.
• Laparoscopic excision (cutting lesions out) is the surgical gold standard — choose a surgeon who does it regularly, not occasional ablation.
• Endometriosis is not cured by pregnancy or by hysterectomy alone; symptoms can return if lesions remain or periods resume.
• Dienogest and the Mirena IUD are the long-term medical workhorses; GnRH analogues are short-term "bridges" needing add-back therapy.
• Persistent period pain that disrupts your life, deep pain during sex, or trouble conceiving all warrant a gynaecology review — do not wait years.

The single most important fact about endometriosis in India is that diagnosis is routinely delayed by 7 to 10 years after symptoms begin. Indian surveys and clinic data report that the average woman sees several clinicians before the condition is named — often after being told her pain is "normal periods," "stress," or a "married life" problem.

This gap is global, but it is worse here because severe period pain is so culturally normalised and because many primary-care doctors are not trained to spot the pattern. The longer the delay, the more disease can progress. Knowing the warning signs — and insisting on a referral — is the first step. For why the system fails women, see the challenges in diagnosing and treating endometriosis.

The symptom pattern that should prompt evaluation is progressive: period pain that worsens year on year, pain starting a day or two before bleeding and continuing through it, deep pain during sex (dyspareunia), pain when opening your bowels during periods (dyschezia), pain on urination during periods, and difficulty conceiving. Any one symptom can be missed — the combination should trigger referral. If your main problem is the cramps themselves, painful periods (dysmenorrhea) covers what is and is not normal.

First-line workup is a pelvic examination plus transvaginal ultrasound. A skilled sonographer can spot ovarian endometriomas ("chocolate cysts"), deep nodules and pouch-of-Douglas obliteration. MRI is added when deep disease is suspected, typically Rs 6,000–12,000 in private centres and free or subsidised at AIIMS, PGI Chandigarh, JIPMER and CMC Vellore. CA-125 is non-specific and is not used to diagnose endometriosis, though it occasionally helps track severe disease.

Definitive diagnosis traditionally needed laparoscopy with biopsy, but the 2022 ESHRE guidelines — now followed by Indian specialists — accept clinical and imaging diagnosis as a valid basis for starting treatment when the symptom pattern is classic. This means many women can begin effective medication earlier, without waiting for surgery.

Endometriosis is staged I to IV (rASRM system) based on lesion location, depth and adhesions seen at laparoscopy. Stage does not predict pain well — a woman with stage I disease can have severe pain, while stage IV may cause little pain and show up only as infertility. Stage matters more for surgical planning and fertility counselling than for predicting how much it hurts.

There are three clinical phenotypes: superficial peritoneal disease (small implants on the pelvic lining); ovarian endometriomas (the "chocolate cysts" inside ovaries); and deep infiltrating endometriosis (DIE — nodules deeper than 5 mm, often on the rectovaginal septum, uterosacral ligaments, bladder or bowel). DIE causes the most severe pain and the most challenging surgery.

Ovarian endometriomas larger than 3–4 cm usually need surgical removal for symptoms, fertility planning, or to rule out anything sinister. But surgery on an endometrioma can lower ovarian reserve, so fertility counselling — including an AMH and ovarian reserve test — should come first if you may want children. To understand cysts more broadly, see ovarian cysts: types and when to worry.

Adenomyosis often coexists with endometriosis (roughly 20–30% overlap) and changes the conversation, because uterine-targeted treatments such as a Mirena IUD or hysterectomy come into play. The two are biologically related but anatomically different — see adenomyosis vs endometriosis for a side-by-side comparison.

NSAIDs are still the first-line medication for acute pain. Mefenamic acid 500 mg three times daily (Indian brands include Meftal-Spas) and ibuprofen 400–600 mg three times daily (Brufen, Ibugesic) reduce prostaglandin-driven pain and modestly cut menstrual blood loss. They work best started a day before pain is expected rather than waiting until it is severe. Cost is roughly Rs 30–100 per period.

Combined oral contraceptive pills are the standard hormonal first line. Brands such as Yasmin, Yamini and Femilon are commonly prescribed in a continuous (skip-the-placebo) regimen to suppress periods for 3–6 months at a time, which reduces lesion activity and pain in most women. Cost is around Rs 100–400 per month. For how this works in practice, see using the pill to regulate periods.

Combined pills do not cure endometriosis — they suppress it, and symptoms typically return within 3–6 months of stopping. They are not for everyone: contraindications include migraine with aura, smoking over age 35, uncontrolled high blood pressure, a history of venous thromboembolism, severe liver disease and breast cancer. Women with these should use progestin-only options instead.

Progestin-only options include oral norethisterone, dienogest 2 mg daily (Indian brand Dronis-2, about Rs 800–1,500 per month), and the depot medroxyprogesterone (DMPA) injection every 3 months. Dienogest has the strongest evidence specifically for endometriosis pain and is increasingly first-line in Indian specialist clinics. Side effects can include breakthrough bleeding, mood change and weight gain in some women.

The levonorgestrel-releasing intrauterine system (LNG-IUS), best known as Mirena, is a mainstay of long-term medical management — especially when adenomyosis coexists. Instead of circulating hormone through the whole body like a pill, it delivers about 20 micrograms of levonorgestrel a day directly into the uterus, which means fewer systemic side effects such as nausea or hormonal acne. By thinning the lining and damping local inflammation, it eases both heavy bleeding and deep pelvic pain.

Cost in major Indian hospitals typically runs Rs 14,000–22,000 including insertion. That sounds steep for one visit, but over its 5–8-year lifespan it works out to under Rs 300 a month — one of the most cost-effective options available. A persistent myth holds that a "foreign object" in the womb causes permanent infertility or can travel through the body; in reality the device stays local and its effect is fully reversible. For how it compares with the copper coil, see copper IUD vs Mirena in India.

The first 3 to 6 months are an adjustment phase, often with irregular spotting as the lining settles. This is expected and is not a sign of "trapped" or "dirty" blood — understanding this prevents premature removal. Insertion is best timed in the last days of a period, when the cervix is softer, and many gynaecologists suggest an NSAID such as mefenamic acid an hour beforehand to dull cramping.

Mirena is fertility-sparing: once a clinician removes it, fertility returns quickly because systemic hormone levels stay negligible. That makes it a good "holding pattern" for women who are not ready for a family but need to halt disease progression, and it removes the mental load of a daily pill — a common reason treatment fails when doses are missed. If heavy bleeding is your dominant symptom, see heavy menstrual bleeding (menorrhagia).

GnRH analogues are the heavy artillery: they switch the ovaries off, inducing a temporary "pseudo-menopause" that starves lesions of the estrogen they need. They include agonists such as leuprolide (Lupride) and goserelin (Zoladex), plus the newer oral GnRH antagonist relugolix. They are mainly used for stage III–IV disease where pills or dienogest have not worked. The trade-off is intense menopausal effects — hot flushes, night sweats and vaginal dryness. A monthly leuprolide injection typically costs Rs 3,500–6,500, and prices are lower in government settings.

The main limit is bone-density loss, a real concern given how many Indian women already have low vitamin D and calcium. To protect bone and ease side effects, guidelines strongly recommend "add-back therapy" — a small dose of hormones (often tibolone, or a low-dose estrogen-progestin combination) alongside the GnRH drug, started from the first month rather than waiting for symptoms to become unbearable. Ask your doctor to check vitamin D and B12 before you start.

GnRH analogues are rarely a permanent answer. They work as a strategic bridge: for 3–6 months before planned excision surgery to quieten the pelvis; before IVF in selected women with severe disease; or for short-term relief when pain is disabling. Once stopped, the cycle resumes and symptoms often return within 3–6 months unless followed by surgery or long-term maintenance with dienogest or Mirena.

Indian guidance generally caps initial GnRH therapy at six months. If it must run longer, a DEXA bone-density scan becomes essential to protect skeletal health. Because the temporary "menopausal" state can be culturally jarring and mistaken for premature ageing or infertility, it helps to explain to family that it is fully reversible. Keeping a simple pain diary makes it easier to judge benefit and plan the move to a sustainable long-term plan.

Laparoscopic excision of endometriosis is the surgical gold standard. Done well by a specialist, it can dramatically reduce pain and improve fertility. The key word is excision — physically cutting lesions out — rather than ablation (burning the surface), which has higher recurrence rates and is no longer recommended for deep disease. For how keyhole surgery works, see laparoscopy for women in India.

Indian costs vary widely. Government tertiary centres (AIIMS Delhi, PGI Chandigarh, JIPMER, CMC Vellore) offer surgery at minimal or no cost for eligible patients. Private centres charge roughly Rs 80,000 to Rs 3,50,000 depending on complexity, surgeon expertise and city. Bowel or bladder involvement needs a multidisciplinary team and can push private costs to Rs 3,00,000–5,00,000.

Excision improves pain in about 70–80% of women, often for years. After surgery for infertility, pregnancy rates are roughly 40–60% within 18 months for stage I–II disease and 30–40% for stage III–IV. Recurrence is around 20% at five years for excision and higher for ablation.

Choose a surgeon specifically trained in advanced endometriosis. Reasonable questions to ask: how many endometriosis surgeries do you do a year (look for more than 50); do you perform excision rather than ablation; do you work with a colorectal surgeon and urologist when bowel or bladder is involved; and what is your recurrence rate. A general gynaecologist doing the occasional case is not the same as an excision specialist.

Endometriosis contributes to a large share of infertility consultations in India. It can distort pelvic anatomy, form endometriomas that damage healthy ovarian tissue, and create chronic inflammation that affects egg and sperm quality. A useful early step is an Anti-Müllerian Hormone (AMH) test (about Rs 1,500–2,500 at major labs), because endometriosis can deplete ovarian reserve. For the full picture, read endometriosis and infertility.

The pathway in 2026 is individualised by stage and age. For stage I–II disease, laparoscopic excision can improve natural conception by restoring anatomy. For stage III–IV disease, or women over 30 with low AMH, IVF is often recommended first because further surgery may reduce ovarian reserve. A common strategy is 2–3 months of GnRH agonist before embryo transfer in selected severe cases. For costs and success rates, see IVF in India. Choose a clinic registered under the ART (Regulation) Act 2021.

Pregnancy is often a temporary respite, not a cure: the high progesterone of pregnancy suppresses estrogen-dependent lesions, and many women have pain-free months. Breastfeeding can extend this if periods stay away. But symptoms typically return once regular cycles resume — "just have a baby" is not a treatment, and is poor advice for women who are struggling to conceive in the first place.

If you do conceive, manage pain cautiously. Paracetamol (Dolo 650, Calpol) is the mainstay across all trimesters. NSAIDs such as ibuprofen and naproxen must be avoided after 30 weeks, as late-pregnancy use can prematurely close the fetal ductus arteriosus and affect fetal kidneys. Hormonal treatments (dienogest, the pill) are stopped entirely in pregnancy. Warm (not hot) compresses, gentle prenatal yoga under a trained instructor, and pelvic physiotherapy can help.

As estrogen falls at menopause, the "fuel" for endometriosis diminishes and most women improve. But for those who had deep infiltrating disease or extensive adhesions for years — often because of the long diagnostic delay — pain can persist. A "frozen pelvis" of scar tissue binding bladder, bowel and uterus can cause chronic pelvic pain regardless of hormone levels. For the wider menopause picture in Indian women, see perimenopause symptoms.

Hormone Replacement Therapy decisions need an individualised approach. If HRT is needed for hot flushes or night sweats in a woman with an endometriosis history, a continuous combined estrogen-plus-progestin regimen is preferred — even after hysterectomy — because estrogen alone can reactivate dormant lesions. Tibolone is an alternative that manages symptoms while minimising stimulation of residual disease. For options and costs, see hormone replacement therapy in India.

Surgical menopause — removing both ovaries, usually with a hysterectomy — is sometimes considered after age 45 once the family is complete and pain is refractory to everything else. It is a major, irreversible decision: the abrupt loss of protective hormones raises cardiovascular and osteoporosis risk, so it needs lifelong calcium and vitamin D, regular DEXA scans, and a discussion about add-back therapy.

New or worsening pelvic pain in a post-menopausal woman with an endometriosis history is a red flag that needs investigation. Malignant change in endometriosis is rare (around 1% of cases) but must be excluded, usually with pelvic MRI or transvaginal ultrasound. Keep a symptom diary and a file of previous operative notes and biopsy reports — they are invaluable to your gynaecologist. New bloating, bowel changes or localised pelvic pain deserve prompt review.

Lifestyle interventions support — but do not replace — medical and surgical treatment. An anti-inflammatory eating pattern (more vegetables, fruit and omega-3-rich fish; less processed meat and refined carbohydrate) has modest evidence for easing pain; see the endometriosis diet. Regular moderate exercise lowers pain perception and supports mood, and good sleep and stress management help pain modulation.

Pelvic floor physiotherapy is genuinely useful for endometriosis-related chronic pelvic pain, especially with deep pain during sex or pain that persists after surgery. The pelvic floor often tightens in response to chronic pain and becomes a second pain source. Trained physiotherapists in major Indian cities charge roughly Rs 800–2,000 per session. For pain during intimacy specifically, see pelvic pain during arousal and intercourse.

Mental health care is part of comprehensive treatment. Years of unbelieved pain, missed work, strained relationships and fertility worry contribute to anxiety and low mood. Chronic-pain-adapted cognitive behavioural therapy helps and is available through major hospitals and many private practitioners. Living with persistent pain is exhausting and real — read chronic pain isn't laziness.

Multidisciplinary care — a gynaecologist, pain specialist, pelvic floor physiotherapist, mental health professional and, when needed, a colorectal or urological surgeon — gives the best outcomes in moderate to severe disease. Few Indian centres have formal endometriosis clinics yet, but the model is growing.

Book a gynaecology review — and ask specifically about endometriosis — if you have any of the patterns below. You do not have to wait years or "prove" your pain first.

Seek urgent care for sudden severe one-sided pelvic pain with faintness, fever or vomiting (which can signal a cyst complication or other emergency), or for heavy bleeding that soaks through protection hourly.

Typical 2026 out-of-pocket ranges: an initial private gynaecology consultation Rs 500–2,500 (free or Rs 50–200 at government hospitals); transvaginal ultrasound Rs 1,000–3,000; pelvic MRI Rs 6,000–12,000; Mirena IUD Rs 14,000–22,000 inserted; a month of dienogest Rs 800–1,500; a monthly leuprolide injection Rs 3,500–8,000; and laparoscopic excision Rs 80,000–3,50,000 in private settings, free or subsidised at government tertiary centres.

Ayushman Bharat PM-JAY covers gynaecological surgery including laparoscopic excision for eligible families up to Rs 5 lakh per family per year, though it covers the procedure rather than all medications. CGHS, ECHS and ESI schemes cover consultation, surgery and many medications at empanelled hospitals. Private insurance varies — many policies cover surgery but not long-term hormone therapy, and many still exclude fertility treatment.

Patient support is led by the Endometriosis Society of India, which runs awareness drives, maintains a specialist directory and runs peer-support groups in several cities. Online groups offer peer-to-peer connection, and the yellow-themed endometriosis awareness campaign in March raises visibility.

Workplace accommodation for severe, chronic-pain endometriosis is in principle available under the Rights of Persons with Disabilities Act 2016, though enforcement is uneven. Some Indian employers have introduced menstrual leave or chronic-illness flexibility; getting reasonable accommodation in writing from HR is increasingly possible in formal-sector jobs.

• ESHRE Guideline: Endometriosis (2022)
• WHO — Endometriosis fact sheet
• ACOG — Endometriosis (FAQ)
• NHS — Endometriosis: Treatment
• NICE Guideline NG73 — Endometriosis: diagnosis and management
• Ayushman Bharat PM-JAY (National Health Authority)